These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28333999)

  • 1. Validation of questionnaire-reported hearing with medical records: A report from the Swiss Childhood Cancer Survivor Study.
    Weiss A; Sommer G; Kuonen R; Scheinemann K; Grotzer M; Kompis M; Kuehni CE;
    PLoS One; 2017; 12(3):e0174479. PubMed ID: 28333999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term auditory complications after childhood cancer: A report from the Swiss Childhood Cancer Survivor Study.
    Weiss A; Sommer G; Kasteler R; Scheinemann K; Grotzer M; Kompis M; Kuehni CE;
    Pediatr Blood Cancer; 2017 Feb; 64(2):364-373. PubMed ID: 27650356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hearing loss and quality of life in survivors of paediatric CNS tumours and other cancers.
    Weiss A; Sommer G; Schindera C; Wengenroth L; Karow A; Diezi M; Michel G; Kuehni CE;
    Qual Life Res; 2019 Feb; 28(2):515-521. PubMed ID: 30306534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of self-reported cardiovascular problems in childhood cancer survivors by contacting general practitioners: feasibility and results.
    Hau EM; Sláma T; Essig S; Michel G; Wengenroth L; Bergstraesser E; von der Weid NX; Schindera C; Kuehni CE
    BMC Prim Care; 2024 Mar; 25(1):81. PubMed ID: 38459512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hearing loss after platinum treatment is irreversible in noncranial irradiated childhood cancer survivors.
    Clemens E; de Vries AC; Am Zehnhoff-Dinnesen A; Tissing WJ; Loonen JJ; Pluijm SF; van Dulmen-den Broeder E; Bresters D; Versluys B; Kremer LC; van der Pal HJ; Neggers SJ; van Grotel M; M van den Heuvel-Eibrink M
    Pediatr Hematol Oncol; 2017 Mar; 34(2):120-129. PubMed ID: 28590156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platinum-induced hearing loss after treatment for childhood cancer.
    van As JW; van den Berg H; van Dalen EC
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD010181. PubMed ID: 27486906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severity of hearing loss after platinum chemotherapy in childhood cancer survivors.
    Strebel S; Mader L; Sláma T; Waespe N; Weiss A; Parfitt R; Am Zehnhoff-Dinnesen A; Kompis M; von der Weid NX; Ansari M; Kuehni CE
    Pediatr Blood Cancer; 2022 Sep; 69(9):e29755. PubMed ID: 35723448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation and Management of Hearing Loss in Survivors of Childhood and Adolescent Cancers: A Report From the Children's Oncology Group.
    Bass JK; Knight KR; Yock TI; Chang KW; Cipkala D; Grewal SS
    Pediatr Blood Cancer; 2016 Jul; 63(7):1152-62. PubMed ID: 26928933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No evidence of response bias in a population-based childhood cancer survivor questionnaire survey - Results from the Swiss Childhood Cancer Survivor Study.
    Rueegg CS; Gianinazzi ME; Michel G; Zwahlen M; von der Weid NX; Kuehni CE;
    PLoS One; 2017; 12(5):e0176442. PubMed ID: 28463966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overweight in childhood cancer survivors: the Swiss Childhood Cancer Survivor Study.
    Belle FN; Weiss A; Schindler M; Goutaki M; Bochud M; Zimmermann K; von der Weid N; Ammann RA; Kuehni CE
    Am J Clin Nutr; 2018 Jan; 107(1):3-11. PubMed ID: 29381792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Hearing Impairment With Neurocognition in Survivors of Childhood Cancer.
    Bass JK; Liu W; Banerjee P; Brinkman TM; Mulrooney DA; Gajjar A; Pappo AS; Merchant TE; Armstrong GT; Srivastava D; Robison LL; Hudson MM; Krull KR
    JAMA Oncol; 2020 Sep; 6(9):1363-1371. PubMed ID: 32729886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-reported and record-collected late effects in long-term survivors of childhood cancer: a population-based cohort study of the childhood cancer registry of the Rhône-Alpes region (ARCERRA).
    Casagranda L; Trombert-Paviot B; Faure-Conter C; Bertrand Y; Plantaz D; Berger C
    Pediatr Hematol Oncol; 2013 Apr; 30(3):195-207. PubMed ID: 23484904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Auditory complications in childhood cancer survivors: a report from the childhood cancer survivor study.
    Whelan K; Stratton K; Kawashima T; Leisenring W; Hayashi S; Waterbor J; Blatt J; Sklar CA; Packer R; Mitby P; Robison LL; Mertens AC
    Pediatr Blood Cancer; 2011 Jul; 57(1):126-34. PubMed ID: 21328523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concordance between the chang and the International Society of Pediatric Oncology (SIOP) ototoxicity grading scales in patients treated with cisplatin for medulloblastoma.
    Bass JK; Huang J; Onar-Thomas A; Chang KW; Bhagat SP; Chintagumpala M; Bartels U; Gururangan S; Hassall T; Heath JA; McCowage G; Cohn RJ; Fisher MJ; Robinson G; Broniscer A; Gajjar A; Gurney JG
    Pediatr Blood Cancer; 2014 Apr; 61(4):601-5. PubMed ID: 24504791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer's positive flip side: posttraumatic growth after childhood cancer.
    Gianinazzi ME; Rueegg CS; Vetsch J; Lüer S; Kuehni CE; Michel G;
    Support Care Cancer; 2016 Jan; 24(1):195-203. PubMed ID: 26003421
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The "Muenster classification" of high frequency hearing loss following cisplatin chemotherapy].
    Schmidt CM; Bartholomäus E; Deuster D; Heinecke A; Dinnesen AG
    HNO; 2007 Apr; 55(4):299-306. PubMed ID: 16437215
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observational study of prevalence of long-term Raynaud-like phenomena and neurological side effects in testicular cancer survivors.
    Brydøy M; Oldenburg J; Klepp O; Bremnes RM; Wist EA; Wentzel-Larsen T; Hauge ER; Dahl O; Fosså SD
    J Natl Cancer Inst; 2009 Dec; 101(24):1682-95. PubMed ID: 19940282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Late effects in survivors of childhood CNS tumors treated on Head Start I and II protocols.
    Saha A; Salley CG; Saigal P; Rolnitzky L; Goldberg J; Scott S; Olshefski R; Hukin J; Sands SA; Finlay J; Gardner SL
    Pediatr Blood Cancer; 2014 Sep; 61(9):1644-52; quiz 1653-72. PubMed ID: 24789527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment-induced hearing loss and adult social outcomes in survivors of childhood CNS and non-CNS solid tumors: Results from the St. Jude Lifetime Cohort Study.
    Brinkman TM; Bass JK; Li Z; Ness KK; Gajjar A; Pappo AS; Armstrong GT; Merchant TE; Srivastava DK; Robison LL; Hudson MM; Gurney JG
    Cancer; 2015 Nov; 121(22):4053-61. PubMed ID: 26287566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970-99: a report from the Childhood Cancer Survivor Study cohort.
    Gibson TM; Mostoufi-Moab S; Stratton KL; Leisenring WM; Barnea D; Chow EJ; Donaldson SS; Howell RM; Hudson MM; Mahajan A; Nathan PC; Ness KK; Sklar CA; Tonorezos ES; Weldon CB; Wells EM; Yasui Y; Armstrong GT; Robison LL; Oeffinger KC
    Lancet Oncol; 2018 Dec; 19(12):1590-1601. PubMed ID: 30416076
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.